Potential of phage depolymerase for the treatment of bacterial biofilms

References

• No authors listed. United Nations meeting on antimicrobial resistance. Bull World Health Organ. 2016;94(9):638–19. doi: 10.2471/BLT.16.020916
   PubMed Web of Science ®Google Scholar
• Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–1322. doi: 10.1126/science.284.5418.1318
   PubMed Web of Science ®Google Scholar
• Wang S, Ding Q, Zhang Y, et al. Evolution of virulence, fitness, and carbapenem resistance transmission in ST23 hypervirulent Klebsiella pneumoniae with the capsular polysaccharide synthesis gene wcaJ Inserted via insertion sequence elements. Microbiol Spectr. 2022;10(6):e0240022. doi: 10.1128/spectrum.02400-22
   PubMed Web of Science ®Google Scholar
• Caldara M, Belgiovine C, Secchi E, et al. Environmental, microbiological, and immunological features of bacterial biofilms associated with implanted medical devices. Clin Microbiol Rev. 2022;35(2):e0022120. doi: 10.1128/cmr.00221-20
   PubMed Web of Science ®Google Scholar
• Singh A, Amod A, Pandey P, et al. Bacterial biofilm infections, their resistance to antibiotics therapy and current treatment strategies. Biomed Mater. 2022;17(2):17. doi: 10.1088/1748-605X/ac50f6
   Google Scholar
• Rasool FN, Saavedra MA, Pamba S, et al. Isolation and characterization of human pathogenic multidrug resistant bacteria associated with plastic litter collected in Zanzibar. J Hazard Mater. 2021;405:124591. doi: 10.1016/j.jhazmat.2020.124591
   PubMed Web of Science ®Google Scholar
• Shahed-Al-Mahmud M, Roy R, Sugiokto FG, et al. Phage φAB6-borne depolymerase combats Acinetobacter baumannii biofilm formation and infection. Antibiotics. 2021;10(3):10. doi: 10.3390/antibiotics10030279
   Google Scholar
• Li M, Wang H, Chen L, et al. Identification of a phage-derived depolymerase specific for KL47 capsule of Klebsiella pneumoniae and its therapeutic potential in mice. Virol Sin. 2022;37(4):538–546. doi: 10.1016/j.virs.2022.04.005
   PubMed Web of Science ®Google Scholar
• Timoshina OY, Kasimova AA, Shneider MM, et al. Loss of a branch sugar in the Acinetobacter baumannii K3-type capsular polysaccharide due to Frameshifts in the gtr6 glycosyltransferase gene leads to susceptibility to phage APK37.1. Microbiol Spectr. 2023;11(1):e0363122. doi: 10.1128/spectrum.03631-22
   PubMed Web of Science ®Google Scholar
• Pires DP, Oliveira H, Melo LD, et al. Bacteriophage-encoded depolymerases: their diversity and biotechnological applications. Appl Microbiol Biotechnol. 2016;100(5):2141–2151. doi: 10.1007/s00253-015-7247-0
   PubMed Web of Science ®Google Scholar
• Drulis-Kawa Z, Majkowska-Skrobek G, Maciejewska B. Bacteriophages and phage-derived proteins–application approaches. Curr Med Chem. 2015;22(14):1757–1773. doi: 10.2174/0929867322666150209152851
   PubMed Web of Science ®Google Scholar
• Topka-Bielecka G, Dydecka A, Necel A, et al. Bacteriophage-derived depolymerases against bacterial biofilm. Antibiotics. 2021;10(2):10. doi: 10.3390/antibiotics10020175
   Google Scholar
• Majkowska-Skrobek G, Latka A, Berisio R, et al. Capsule-Targeting Depolymerase, derived from Klebsiella KP36 phage, as a tool for the development of anti-virulent strategy. Viruses. 2016;8(12):324. doi: 10.3390/v8120324
   PubMed Web of Science ®Google Scholar
• Abdelkader K, Gutierrez D, Latka A, et al. The specific capsule depolymerase of phage PMK34 sensitizes Acinetobacter baumannii to serum killing. Antibiotics. 2022;11(5):11. doi: 10.3390/antibiotics11050677
   Google Scholar
• Wu Y, Wang R, Xu M, et al. A novel polysaccharide depolymerase encoded by the phage SH-KP152226 confers specific activity against multidrug-resistant Klebsiella pneumoniae via biofilm degradation. Front Microbiol. 2019;10:2768. doi: 10.3389/fmicb.2019.02768
   PubMed Web of Science ®Google Scholar
• Chen X, Liu M, Zhang P, et al. Phage-Derived Depolymerase as an antibiotic adjuvant against Multidrug-Resistant Acinetobacter baumannii. Front Microbiol. 2022;13:845500. doi: 10.3389/fmicb.2022.845500
   PubMed Web of Science ®Google Scholar
• Sutherland IW. The biofilm matrix–an immobilized but dynamic microbial environment. Trends Microbiol. 2001;9(5):222–227. doi: 10.1016/S0966-842X(01)02012-1
   PubMed Web of Science ®Google Scholar
• Belfield K, Bayston R, Birchall JP, et al. Do orally administered antibiotics reach concentrations in the middle ear sufficient to eradicate planktonic and biofilm bacteria? A review. Int J Pediatr Otorhinolaryngol. 2015;79(3):296–300. doi: 10.1016/j.ijporl.2015.01.003
   PubMed Web of Science ®Google Scholar
• Hoiby N, Bjarnsholt T, Givskov M, et al. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35(4):322–332. doi: 10.1016/j.ijantimicag.2009.12.011
   PubMed Web of Science ®Google Scholar
• Kostakioti M, Hadjifrangiskou M, Hultgren SJ. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med. 2013;3(4):a010306. doi: 10.1101/cshperspect.a010306
   PubMed Web of Science ®Google Scholar
• Jang H, Rusconi R, Stocker R. Biofilm disruption by an air bubble reveals heterogeneous age-dependent detachment patterns dictated by initial extracellular matrix distribution. NPJ Biofilms Microbiomes. 2017;3(1):6. doi: 10.1038/s41522-017-0014-5
   PubMedGoogle Scholar
• Abebe GM. The role of bacterial biofilm in antibiotic resistance and food contamination. Int J Microbiol. 2020;2020:1705814. doi: 10.1155/2020/1705814
   PubMed Web of Science ®Google Scholar
• Petrova OE, Sauer K. Sticky situations: key components that control bacterial surface attachment. J Bacteriol. 2012;194(10):2413–2425. doi: 10.1128/JB.00003-12
   PubMed Web of Science ®Google Scholar
• Jamal M, Ahmad W, Andleeb S, et al. Bacterial biofilm and associated infections. J Chin Med Assoc. 2018;81(1):7–11. doi: 10.1016/j.jcma.2017.07.012
   PubMed Web of Science ®Google Scholar
• Habash M, Reid G. Microbial biofilms: their development and significance for medical device-related infections. J Clin Pharmacol. 1999;39(9):887–898. doi: 10.1177/00912709922008506
   PubMed Web of Science ®Google Scholar
• Legoux R, Lelong P, Jourde C, et al. N-acetyl-heparosan lyase of Escherichia coli K5: gene cloning and expression. J Bacteriol. 1996;178(24):7260–7264. doi: 10.1128/jb.178.24.7260-7264.1996
   PubMed Web of Science ®Google Scholar
• Blanco-Cabra N, Paetzold B, Ferrar T, et al. Characterization of different alginate lyases for dissolving Pseudomonas aeruginosa biofilms. Sci Rep. 2020;10(1):9390. doi: 10.1038/s41598-020-66293-2
   PubMed Web of Science ®Google Scholar
• Lahiri D, Nag M, Dey A, et al. Immobilized enzymes as potent antibiofilm agent. Biotechnol Prog. 2022;38(5):e3281. doi: 10.1002/btpr.3281
   PubMed Web of Science ®Google Scholar
• Woolcock JB. The capsule of Streptococcus equi. J Gen Microbiol. 1974;85(2):372–375. doi: 10.1099/00221287-85-2-372
   PubMedGoogle Scholar
• Latka A, Maciejewska B, Majkowska-Skrobek G, et al. Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process. Appl Microbiol Biotechnol. 2017;101(8):3103–3119. doi: 10.1007/s00253-017-8224-6
   PubMed Web of Science ®Google Scholar
• Singh R, Sahore S, Kaur P, et al. Penetration barrier contributes to bacterial biofilm-associated resistance against only select antibiotics, and exhibits genus-, strain- and antibiotic-specific differences. Pathog Dis. 2016;74(6):ftw056. doi: 10.1093/femspd/ftw056
   PubMed Web of Science ®Google Scholar
• Singh R, Ray P, Das A, et al. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother. 2010;65(9):1955–1958. doi: 10.1093/jac/dkq257
   PubMed Web of Science ®Google Scholar
• Nguyen H, Nguyen TH, Otto M. The staphylococcal exopolysaccharide PIA - Biosynthesis and role in biofilm formation, colonization, and infection. Comput Struct Biotechnol J. 2020;18:3324–3334. doi: 10.1016/j.csbj.2020.10.027
   PubMed Web of Science ®Google Scholar
• Nuryastuti T, Krom BP. Ica-status of clinical Staphylococcus epidermidis strains affects adhesion and aggregation: a thermodynamic analysis. Antonie Van Leeuwenhoek. 2017;110(11):1467–1474. doi: 10.1007/s10482-017-0899-2
   PubMed Web of Science ®Google Scholar
• Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother. 2000;44(7):1818–1824. doi: 10.1128/AAC.44.7.1818-1824.2000
   PubMed Web of Science ®Google Scholar
• Hoyle BD, Alcantara J, Costerton JW. Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin. Antimicrob Agents Chemother. 1992;36(9):2054–2056. doi: 10.1128/AAC.36.9.2054
   PubMed Web of Science ®Google Scholar
• Abdi-Ali A, Mohammadi-Mehr M, Agha AY. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa. Int J Antimicrob Agents. 2006;27(3):196–200. doi: 10.1016/j.ijantimicag.2005.10.007
   PubMed Web of Science ®Google Scholar
• Wu Y, Klapper I, Stewart PS. Hypoxia arising from concerted oxygen consumption by neutrophils and microorganisms in biofilms. Pathog Dis. 2018;76(4). doi: 10.1093/femspd/fty043
   Web of Science ®Google Scholar
• Pabst B, Pitts B, Lauchnor E, et al. Gel-entrapped Staphylococcus aureus bacteria as models of biofilm infection exhibit growth in dense aggregates, oxygen limitation, antibiotic tolerance, and heterogeneous gene expression. Antimicrob Agents Chemother. 2016;60(10):6294–6301. doi: 10.1128/AAC.01336-16
   PubMed Web of Science ®Google Scholar
• Uribe-Alvarez C, Chiquete-Felix N, Contreras-Zentella M, et al. Staphylococcus epidermidis: metabolic adaptation and biofilm formation in response to different oxygen concentrations. Pathog Dis. 2016;74(1):ftv111. doi: 10.1093/femspd/ftv111
   PubMed Web of Science ®Google Scholar
• Pulukkody AC, Yung YP, Donnarumma F, et al. Spatially resolved analysis of Pseudomonas aeruginosa biofilm proteomes measured by laser ablation sample transfer. PLoS One. 2021;16(7):e0250911. doi: 10.1371/journal.pone.0250911
   PubMed Web of Science ®Google Scholar
• Ramos-Gonzalez MI, Travieso ML, Soriano MI, et al. Genetic dissection of the regulatory network associated with high c-di-GMP levels in Pseudomonas putida KT2440. Front Microbiol. 2016;7:1093. doi: 10.3389/fmicb.2016.01093
   PubMed Web of Science ®Google Scholar
• Mills E, Petersen E, Kulasekara BR, et al. A direct screen for c-di-GMP modulators reveals a salmonella typhimurium periplasmic ʟ-arginine–sensing pathway. Sci Signal. 2015;8(380):ra57. doi: 10.1126/scisignal.aaa1796
   PubMed Web of Science ®Google Scholar
• Anderl JN, Zahller J, Roe F, et al. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother. 2003;47(4):1251–1256. doi: 10.1128/AAC.47.4.1251-1256.2003
   PubMed Web of Science ®Google Scholar
• Hunter RC, Beveridge TJ. Application of a pH-sensitive fluoroprobe (C-SNARF-4) for pH microenvironment analysis in Pseudomonas aeruginosa biofilms. Appl Environ Microbiol. 2005;71(5):2501–2510. doi: 10.1128/AEM.71.5.2501-2510.2005
   PubMed Web of Science ®Google Scholar
• Venglarcik JR, Blair LL, Dunkle LM. pH-dependent oxacillin tolerance of Staphylococcus aureus. Antimicrob Agents Chemother. 1983;23(2):232–235. doi: 10.1128/AAC.23.2.232
   PubMed Web of Science ®Google Scholar
• Xu KD, McFeters GA, Stewart PS. Biofilm resistance to antimicrobial agents. Microbiology (Reading). 2000;146(Pt 3):547–549. doi: 10.1099/00221287-146-3-547
   PubMedGoogle Scholar
• Zheng Z, Stewart PS. Penetration of rifampin through Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother. 2002;46(3):900–903. doi: 10.1128/AAC.46.3.900-903.2002
   PubMed Web of Science ®Google Scholar
• Schierholz JM, Beuth J, Pulverer G. Killing effects of antibiotics and two-fold antimicrobial combinations on proliferating and non growing staphylococci. Zentralbl Bakteriol. 1998;288(4):527–539. doi: 10.1016/S0934-8840(98)80072-8
   PubMedGoogle Scholar
• Zimmerli W, Frei R, Widmer AF, et al. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother. 1994;33:959–967.
   PubMed Web of Science ®Google Scholar
• Olsen I. Biofilm-specific antibiotic tolerance and resistance. Eur J Clin Microbiol Infect Dis. 2015;34(5):877–886. doi: 10.1007/s10096-015-2323-z
   PubMed Web of Science ®Google Scholar
• Savage VJ, Chopra I, O’Neill AJ. Staphylococcus aureus biofilms promote horizontal transfer of antibiotic resistance. Antimicrob Agents Chemother. 2013;57(4):1968–1970. doi: 10.1128/AAC.02008-12
   PubMed Web of Science ®Google Scholar
• Kouzel N, Oldewurtel ER, Maier B, et al. Gene transfer efficiency in gonococcal biofilms: role of biofilm Age, architecture, and pilin antigenic variation. J Bacteriol. 2015;197(14):2422–2431. doi: 10.1128/JB.00171-15
   PubMed Web of Science ®Google Scholar
• Tanner WD, Atkinson RM, Goel RK, et al. Horizontal transfer of the blaNDM-1 gene to Pseudomonas aeruginosa and Acinetobacter baumannii in biofilms. FEMS Microbiol Lett. 2017;364(8). doi: 10.1093/femsle/fnx048
   PubMed Web of Science ®Google Scholar
• Fisarova L, Botka T, Du X, et al. Staphylococcus epidermidis phages transduce antimicrobial resistance plasmids and mobilize chromosomal islands. mSphere. 2021;6(3):6. doi: 10.1128/mSphere.00223-21
   Web of Science ®Google Scholar
• Lattar SM, Wu X, Brophy J, et al. A mechanism of unidirectional Transformation, leading to antibiotic resistance, occurs within nasopharyngeal pneumococcal biofilm consortia. MBio. 2018;9(3). doi: 10.1128/mBio.00561-18
   PubMed Web of Science ®Google Scholar
• Uruen C, Chopo-Escuin G, Tommassen J, et al. Biofilms as promoters of bacterial antibiotic resistance and tolerance. Antibiotics. 2020;10(1):10. doi: 10.3390/antibiotics10010003
   Google Scholar
• Driffield K, Miller K, Bostock JM, et al. Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother. 2008;61(5):1053–1056. doi: 10.1093/jac/dkn044
   PubMed Web of Science ®Google Scholar
• Sultan AM, Amer GF, Nabiel Y. Quinolone-resistant uropathogenic E. coli: is there a relation between qnr genes, gyrA gene target site mutation and biofilm formation? J Med Microbiol. 2021;70(10). doi: 10.1099/jmm.0.001432
   PubMed Web of Science ®Google Scholar
• Turkel I, Yildirim T, Yazgan B, et al. Relationship between antibiotic resistance, efflux pumps, and biofilm formation in extended-spectrum β-lactamase producing Klebsiella pneumoniae. J Chemother. 2018;30(6–8):354–363. doi: 10.1080/1120009X.2018.1521773
   PubMed Web of Science ®Google Scholar
• Knight DB, Rudin SD, Bonomo RA, et al. Acinetobacter nosocomialis: defining the role of efflux pumps in resistance to antimicrobial therapy, surface motility, and biofilm formation. Front Microbiol. 2018;9:1902. doi: 10.3389/fmicb.2018.01902
   PubMed Web of Science ®Google Scholar
• Li XF, Shi HQ, Liang Y, et al. Interaction of biofilm and efflux pump in clinical isolates of carbapenem resistant P. aeruginosa. Eur Rev Med Pharmacol Sci. 2022;26(5):1729–1737. doi: 10.26355/eurrev_202203_28242
   PubMed Web of Science ®Google Scholar
• Lin H, Paff ML, Molineux IJ, et al. Therapeutic application of phage capsule depolymerases against K1, K5, and K30 capsulated E. coli in mice. Front Microbiol. 2017;8:2257. doi: 10.3389/fmicb.2017.02257
   PubMed Web of Science ®Google Scholar
• Nimmich W, Schmidt G, Krallmann-Wenzel U. Two different Escherichia coli capsular polysaccharide depolymerases each associated with one of the coliphage φK5 and φK20. FEMS Microbiol Lett. 1991;66(2):137–141. doi: 10.1016/0378-1097(91)90322-2
   PubMedGoogle Scholar
• Domingo-Calap P, Beamud B, Vienne J, et al. Isolation of four lytic phages infecting Klebsiella pneumoniae K22 clinical isolates from Spain. Int J Mol Sci. 2020;21(2):21. doi: 10.3390/ijms21020425
   Web of Science ®Google Scholar
• Gorodnichev RB, Volozhantsev NV, Krasilnikova VM, et al. Novel Klebsiella pneumoniae K23-specific bacteriophages from different families: similarity of depolymerases and their therapeutic potential. Front Microbiol. 2021;12:669618. doi: 10.3389/fmicb.2021.669618
   PubMed Web of Science ®Google Scholar
• Eckstein S, Stender J, Mzoughi S, et al. Isolation and characterization of lytic phage TUN1 specific for Klebsiella pneumoniae K64 clinical isolates from Tunisia. BMC Microbiol. 2021;21(1):186. doi: 10.1186/s12866-021-02251-w
   PubMed Web of Science ®Google Scholar
• Kasimova AA, Arbatsky NP, Timoshina OY, et al. The K26 capsular polysaccharide from Acinetobacter baumannii KZ-1098: structure and cleavage by a specific phage depolymerase. Int j biol macromol. 2021;191:182–191. doi: 10.1016/j.ijbiomac.2021.09.073
   PubMed Web of Science ®Google Scholar
• Drobiazko AY, Kasimova AA, Evseev PV, et al. Capsule-targeting depolymerases derived from Acinetobacter baumannii prophage regions. Int J Mol Sci. 2022;23(9):23. doi: 10.3390/ijms23094971
   Web of Science ®Google Scholar
• Squeglia F, Maciejewska B, Latka A, et al. Structural and functional studies of a Klebsiella phage capsule Depolymerase Tailspike: mechanistic insights into capsular degradation. Structure. 2020;28(6):613–624.e4. doi: 10.1016/j.str.2020.04.015
   PubMed Web of Science ®Google Scholar
• Tu IF, Lin TL, Yang FL, et al. Structural and biological insights into Klebsiella pneumoniae surface polysaccharide degradation by a bacteriophage K1 lyase: implications for clinical use. J Biomed Sci. 2022;29(1):9. doi: 10.1186/s12929-022-00792-4
   PubMed Web of Science ®Google Scholar
• Mushtaq N, Redpath MB, Luzio JP, et al. Treatment of experimental Escherichia coli infection with recombinant bacteriophage-derived capsule depolymerase. J Antimicrob Chemother. 2005;56(1):160–165. doi: 10.1093/jac/dki177
   PubMed Web of Science ®Google Scholar
• Kimura K, Itoh Y. Characterization of poly-γ-glutamate hydrolase encoded by a bacteriophage genome: possible role in phage infection of Bacillus subtilis encapsulated with poly-γ-glutamate. Appl Environ Microbiol. 2003;69(5):2491–2497. doi: 10.1128/AEM.69.5.2491-2497.2003
   PubMed Web of Science ®Google Scholar
• Ely B, Gibbs W, Diez S, et al. The caulobacter crescentus transducing phage Cr30 is a unique member of the T4-like family of myophages. Curr Microbiol. 2015;70(6):854–858. doi: 10.1007/s00284-015-0799-5
   PubMed Web of Science ®Google Scholar
• Yoon BH, Chang HI. Complete genomic sequence of the lactobacillus temperate phage LF1. Arch Virol. 2011;156(10):1909–1912. doi: 10.1007/s00705-011-1082-0
   PubMed Web of Science ®Google Scholar
• Maaroufi H, Levesque RC. Glycoside hydrolase family 32 is present in Bacillus subtilis phages. Virol J. 2015;12(1):157. doi: 10.1186/s12985-015-0373-6
   PubMedGoogle Scholar
• Chua J, Manning PA, Morona R. The shigella flexneri bacteriophage Sf6 tailspike protein (Tsp)/endorhamnosidase is related to the bacteriophage P22 TSP and has a motif common to exo- and endoglycanases, and C-5 epimerases. Microbiology (Reading). 1999;145(7):1649–1659. doi: 10.1099/13500872-145-7-1649
   PubMedGoogle Scholar
• Mushtaq N, Redpath MB, Luzio JP, et al. Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype. Antimicrob Agents Chemother. 2004;48(5):1503–1508. doi: 10.1128/AAC.48.5.1503-1508.2004
   PubMed Web of Science ®Google Scholar
• Smith NL, Taylor EJ, Lindsay AM, et al. Structure of a group a streptococcal phage-encoded virulence factor reveals a catalytically active triple-stranded β-helix. Proc Natl Acad Sci U S A. 2005;102(49):17652–17657. doi: 10.1073/pnas.0504782102
   PubMed Web of Science ®Google Scholar
• Baker JR, Dong S, Pritchard DG. The hyaluronan lyase of Streptococcus pyogenes bacteriophage H4489A. Biochem J. 2002;365(1):317–322. doi: 10.1042/bj20020149
   PubMedGoogle Scholar
• Glonti T, Chanishvili N, Taylor PW. Bacteriophage-derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa. J Appl Microbiol. 2010;108(2):695–702. doi: 10.1111/j.1365-2672.2009.04469.x
   PubMed Web of Science ®Google Scholar
• Cornelissen A, Ceyssens PJ, T’Syen J, et al. The T7-related Pseudomonas putida phage phi15 displays virion-associated biofilm degradation properties. PLoS One. 2011;6:e18597. doi: 10.1371/journal.pone.0018597
   PubMed Web of Science ®Google Scholar
• Liu Y, Mi Z, Mi L, et al. Identification and characterization of capsule depolymerase Dpo48 from Acinetobacter baumannii phage IME200. PeerJ. 2019;7:e6173. doi: 10.7717/peerj.6173
   PubMed Web of Science ®Google Scholar
• Rice CJ, Kelly SA, O’Brien SC, et al. Novel phage-derived depolymerase with activity against Proteus mirabilis biofilms. Microorganisms. 2021;9(10):2172. doi: 10.3390/microorganisms9102172
   PubMed Web of Science ®Google Scholar
• Wang C, Li P, Zhu Y, et al. Identification of a novel Acinetobacter baumannii phage-derived depolymerase and its therapeutic application in mice. Front Microbiol. 2020;11:1407. doi: 10.3389/fmicb.2020.01407
   PubMed Web of Science ®Google Scholar
• Oliveira H, Pinto G, Mendes B, et al. A tailspike with exopolysaccharide depolymerase activity from a New Providencia stuartii phage makes multidrug-resistant bacteria susceptible to serum-mediated killing. Appl Environ Microbiol. 2020;86(13). doi: 10.1128/AEM.00073-20
   Web of Science ®Google Scholar
• Oliveira H, Mendes A, Fraga AG, et al. K2 capsule depolymerase is highly stable, is refractory to resistance, and protects larvae and mice from Acinetobacter baumannii sepsis. Appl Environ Microbiol. 2019;85(17). doi: 10.1128/AEM.00934-19
   PubMed Web of Science ®Google Scholar
• Oliveira H, Costa AR, Ferreira A, et al. Functional analysis and antivirulence properties of a New depolymerase from a myovirus that infects Acinetobacter baumannii capsule K45. J Virol. 2019;93(4). doi: 10.1128/JVI.01163-18
   Web of Science ®Google Scholar
• Pertics BZ, Cox A, Nyul A, et al. Isolation and characterization of a novel lytic bacteriophage against the K2 capsule-Expressing Hypervirulent Klebsiella pneumoniae strain 52145, and Identification of its functional depolymerase. Microorganisms. 2021;9(3):650. doi: 10.3390/microorganisms9030650
   PubMed Web of Science ®Google Scholar
• Hernandez-Morales AC, Lessor LL, Wood TL, et al. Genomic and biochemical characterization of Acinetobacter podophage petty reveals a novel lysis mechanism and tail-associated depolymerase activity. J Virol. 2018;92(6). doi: 10.1128/JVI.01064-17
   PubMed Web of Science ®Google Scholar
• Hsu CR, Lin TL, Pan YJ, et al. Isolation of a bacteriophage specific for a new capsular type of Klebsiella pneumoniae and characterization of its polysaccharide depolymerase. PLoS One. 2013;8(8):e70092. doi: 10.1371/journal.pone.0070092
   PubMed Web of Science ®Google Scholar
• Liu Y, Leung S, Huang Y, et al. Identification of two depolymerases from phage IME205 and their antivirulent functions on K47 capsule of Klebsiella pneumoniae. Front Microbiol. 2020;11:218. doi: 10.3389/fmicb.2020.00218
   PubMed Web of Science ®Google Scholar
• Pan YJ, Lin TL, Chen CC, et al. Klebsiella phage PhiK64-1 encodes multiple depolymerases for multiple host capsular types. J Virol. 2017;91(6):e02457–16. doi: 10.1128/JVI.02457-16
   PubMed Web of Science ®Google Scholar
• Pan YJ, Lin TL, Chen YY, et al. Identification of three podoviruses infecting Klebsiella encoding capsule depolymerases that digest specific capsular types. Microbiol Biotechnol. 2019;12(3):472–486. doi: 10.1111/1751-7915.13370
   Google Scholar
• Hsieh PF, Lin HH, Lin TL, et al. Two T7-like Bacteriophages, K5-2 and K5-4, each encodes two capsule depolymerases: isolation and functional characterization. Sci Rep. 2017;7(1):4624. doi: 10.1038/s41598-017-04644-2
   PubMedGoogle Scholar
• Broudy TB, Pancholi V, Fischetti VA, et al. Induction of lysogenic bacteriophage and phage-associated toxin from group a streptococci during coculture with human pharyngeal cells. Infect Immun. 2001;69(3):1440–1443. doi: 10.1128/IAI.69.3.1440-1443.2001
   PubMed Web of Science ®Google Scholar
• Wong TY, Preston LA, Schiller NL. ALGINATE LYASE: review of major sources and enzyme characteristics, structure-function analysis, biological roles, and applications. Annu Rev Microbiol. 2000;54(1):289–340. doi: 10.1146/annurev.micro.54.1.289
   PubMedGoogle Scholar
• Davidson IW, Lawson CJ, Sutherland IW. An alginate lysate from Azotobacter vinelandii phage. Journal Of General Microbiology. 1977;98(1):223–229. doi: 10.1099/00221287-98-1-223
   PubMedGoogle Scholar
• Chen Y, Li X, Wang S, et al. A novel tail-associated O91-specific polysaccharide depolymerase from a podophage reveals lytic efficacy of Shiga toxin-producing Escherichia coli. Appl Environ Microbiol. 2020;86(9). doi: 10.1128/AEM.00145-20
   Web of Science ®Google Scholar
• Olszak T, Shneider MM, Latka A, et al. The O-specific polysaccharide lyase from the phage LKA1 tailspike reduces Pseudomonas virulence. Sci Rep. 2017;7(1):16302. doi: 10.1038/s41598-017-16411-4
   PubMedGoogle Scholar
• Kaszowska M, Majkowska-Skrobek G, Markwitz P, et al. The mutation in wbaP cps gene cluster selected by phage-borne depolymerase abolishes capsule production and diminishes the virulence of Klebsiella pneumoniae. Int J Mol Sci. 2021;22(21):22. doi: 10.3390/ijms222111562
   Web of Science ®Google Scholar
• Whitfield C. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem. 2006;75(1):39–68. doi: 10.1146/annurev.biochem.75.103004.142545
   PubMedGoogle Scholar
• Majkowska-Skrobek G, Latka A, Berisio R, et al. Phage-borne depolymerases decrease Klebsiella pneumoniae resistance to innate defense mechanisms. Front Microbiol. 2018;9:2517. doi: 10.3389/fmicb.2018.02517
   PubMed Web of Science ®Google Scholar
• Guerrero-Bustamante CA, Dedrick RM, Garlena RA, et al. Toward a phage cocktail for tuberculosis: susceptibility and tuberculocidal action of mycobacteriophages against diverse mycobacterium tuberculosis strains. MBio. 2021;12(3):12. doi: 10.1128/mBio.00973-21
   Web of Science ®Google Scholar
• Li M, Chang R, Lin Y, et al. Phage cocktail powder for Pseudomonas aeruginosa respiratory infections. Int J Pharm. 2021;596:120200. doi: 10.1016/j.ijpharm.2021.120200
   PubMedGoogle Scholar
• Mijbel AB, Gatea KS, Al-Bayati MA, et al. A novel phage cocktail therapy of the urinary tract infection in a mouse model. Arch Razi Inst. 2021;76(5):1229–1236. doi: 10.22092/ari.2021.356004.1762
   PubMedGoogle Scholar
• Jault P, Leclerc T, Jennes S, et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect Dis. 2019;19(1):35–45. doi: 10.1016/S1473-3099(18)30482-1
   PubMed Web of Science ®Google Scholar
• Sarker SA, Sultana S, Reuteler G, et al. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMedicine. 2016;4:124–137. doi: 10.1016/j.ebiom.2015.12.023
   PubMed Web of Science ®Google Scholar
• Golembo M, Puttagunta S, Rappo U, et al. Development of a topical bacteriophage gel targeting Cutibacterium acnes for acne prone skin and results of a phase 1 cosmetic randomized clinical trial. Skin Health Dis. 2022;2(2):e93. doi: 10.1002/ski2.93
   PubMedGoogle Scholar
• Verma V, Harjai K, Chhibber S. Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae. Biofouling. 2010;26(6):729–737. doi: 10.1080/08927014.2010.511196
   PubMed Web of Science ®Google Scholar
• Latka A, Drulis-Kawa Z. Advantages and limitations of microtiter biofilm assays in the model of antibiofilm activity of Klebsiella phage KP34 and its depolymerase. Sci Rep. 2020;10(1):20338. doi: 10.1038/s41598-020-77198-5
   PubMed Web of Science ®Google Scholar
• Luo CH, Hsu YH, Wu WJ, et al. Phage digestion of a bacterial capsule imparts resistance to two antibiotic Agents. Microorganisms. 2021;9(4):794. doi: 10.3390/microorganisms9040794
   PubMed Web of Science ®Google Scholar
• Dunne MW, Aronin SI, Das AF, et al. Sulopenem or ciprofloxacin for the treatment of uncomplicated urinary tract infections in women: a phase 3, randomized trial. Clin Infect Dis. 2023;76(1):66–77. doi: 10.1093/cid/ciac738
   PubMed Web of Science ®Google Scholar
• Chen Y, Sun E, Yang L, et al. Therapeutic application of bacteriophage PHB02 and its putative depolymerase against Pasteurella multocida capsular type a in mice. Front Microbiol. 2018;9:1678. doi: 10.3389/fmicb.2018.01678
   PubMed Web of Science ®Google Scholar
• Mi L, Liu Y, Wang C, et al. Identification of a lytic Pseudomonas aeruginosa phage depolymerase and its anti-biofilm effect and bactericidal contribution to serum. Vir Gen. 2019;55(3):394–405. doi: 10.1007/s11262-019-01660-4
   PubMed Web of Science ®Google Scholar
• Russo A, Gavaruzzi F, Ceccarelli G, et al. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection. 2022;50(1):83–92. doi: 10.1007/s15010-021-01643-4
   PubMed Web of Science ®Google Scholar